for people living with neurological disorders
Our goal is to prevent the progression of disease to enable the progression of the person.
Up to 1 billion people suffer from neurological disorders. The strength of our commitment comes from our personal connections to this cause.
Advances in genetic medicines have validated that AAVs can deliver therapeutic genes directly to the CNS in a well-tolerated and effective manner.
We are driven by a belief that meaningful discovery is born from curiosity, collaboration, and compassion.
Our passionate team is built on a rare and powerful foundation of expertise backed by knowledgeable investors.